
Eli Lilly Unveils Zepbound: A Single-Pen Solution for Obesity Management
Eli Lilly is making strides in obesity management with the release of Zepbound, a new formulation that simplifies dosage into a multi-dose pen, designed to enhance patient accessibility and adherence. This significant innovation is poised to impact the landscape of weight management treatments in profound ways.
Read full article




























